• Polygenic Risk-Based Detection and Treatment of Subclinical Coronary Atherosclerosis in the PROACT Clinical Trials

Presented by Dr. Roukoz Abou-Karam.

• Multidomain Risk Profiles and Disease Progression Across Atherosclerotic Vascular Beds

Presented by Dr. Kelvin Supriami.

• Predictive Utility of Genomics, Inflammation, Cholesterol, and Lipoprotein(a) in Assessing Coronary Artery Disease Risk Across Age and Sex

Presented by Dr. Raysha Farah.

• Polygenic Risk Score-Based Enrichment of Primary Prevention Cohorts for Atherosclerotic Cardiovascular Disease Trials (Samuel A. Levine Early Career Clinical Investigator Award – Finalist)

Presented by Dr. Ozan Unlu.

• Three-Year Outcomes after Deceased Cardiac Donor Heart Transplantation

Presented by Dr. Brian Huang.

• Interactions Between Polygenic Risk Scores and Social Determinants of Health in Coronary Artery Disease: Insights from the UK Biobank

Presented by Carl Sadek.